IDT Australia Limited (ASX:IDT)
Australia
· Delayed Price · Currency is AUD 0.1100
+0.0100 (10.00%)
Apr 24, 2025, 3:57 PM AEST
IDT Australia Company Description
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States.
and internationally. It offers microbiological and analytical testing, clinical packaging, and pharmacy services.
The company also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms.
In addition, it offers mRNA and ADCs. Further, the company provides contract manufacturing services.
IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
IDT Australia Limited
| Country | Australia |
| Founded | 1975 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 100 |
| CEO | Paul McDonald |
Contact Details
Address: 45 Wadhurst Drive Boronia, 3155 Australia | |
| Phone | 61 3 9801 8888 |
| Website | en.idtaus.com.au |
Stock Details
| Ticker Symbol | IDT |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000IDT0 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Paul Anthony McDonald | Chief Executive Officer |
| Vasanthakumar Mahendran | Chief Financial Officer |
| Jim Sosic | Chief Operating Officer |
| Marc Flanders | Director of Commercial, Business Development and Global Sales |
| Paula Coutts | Head of People and Safety |
| Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP | Company Secretary |